Previous 10 | Next 10 |
2023-12-28 07:20:44 ET More on MediWound, Vericel, etc. MediWound Ltd. (MDWD) Q3 2023 Earnings Call Transcript Vericel Corporation (VCEL) Q3 2023 Earnings Call Transcript Vericel Corporation 2023 Q3 - Results - Earnings Call Presentation 3M to join MediWound ...
YAVNE, Israel, Dec. 21, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), the global leader in next-generation enzymatic therapeutics for tissue repair today announced the publication of a peer-reviewed paper, titled “ An Open-label, Proof of Concept Study, Assessing the Effects of...
2023-12-18 01:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-11-21 13:14:09 ET MediWound Ltd. (MDWD) Q3 2023 Earnings Call Transcript November 21, 2023 08:30 AM ET Company Participants Daniel Ferry - LifeSci Advisors Ofer Gonen - Chief Executive Officer Barry Wolfenson - Executive Vice President of Strategy & Corp...
2023-11-21 07:05:36 ET More on MediWound 3M to join MediWound in Phase 3 trial for wound care product MediWound burn therapy NexoBrid launched in US Seeking Alpha’s Quant Rating on MediWound Historical earnings data for MediWound Financial info...
NexoBrid ® commercially launched in U.S. and Japan; Company prioritizes operational resources to meet increased global demand EscharEx ® Phase III study preparations progressing; Protocol submission to FDA expected in first quarter 2024 Cash of $46 million; Opera...
YAVNE, Israel, Nov. 21, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, today announced the appointment of Shmulik Hess, Ph.D. to the positions of Chief Operating Officer and ...
Freightos Limited (CRGO) is expected to report $-0.14 for Q3 2023 Magyar Telekom Telecommunications ADR (MYTAY) is expected to report for Q3 2023 IMAC Holdings Inc. (BACK) is expected to report for Q1 2024 NewJersey Resources Corporation (NJR) is expected to report $0.3 for Q4 2023 ...
MediWound Ltd. (MDWD) is expected to report $-0.45 for Q3 2023
2023-11-20 12:56:52 ET More on MediWound 3M to join MediWound in Phase 3 trial for wound care product MediWound burn therapy NexoBrid launched in US Seeking Alpha’s Quant Rating on MediWound Historical earnings data for MediWound Financial info...
News, Short Squeeze, Breakout and More Instantly...
Funds to be used for clinical development of EscharEx ® to treat diabetic foot ulcers (DFUs) Award advances MediWound’s DFU program and its future revenues four years ahead of original schedule YAVNE, Israel, July 16, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd....
Mölnlycke® Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound Ltd PR Newswire GOTHENBURG, Sweden , July 15, 2024 /PRNewswire/ -- Mölnlycke Health Care, a world-leading MedTech company specialising i...
YAVNE, Israel, July 15, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), the world leader in next-generation enzymatic therapeutics for tissue repair, today announced it has entered into a definitive share purchase agreement with several new and existing investors, including Mölnlycke...